Renaissance Technologies's ABBV Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 928.1K shares of AbbVie Inc. (ABBV) worth $214.89 M, representing 0.28% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 5.5M shares. Largest reduction occurred in Q4 2020, reducing 7.4M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +540,301 | Add 0.00% | 540,300 | $41.34 |
| Q3 2013 | +1.45 M | Add 268.59% | 1.99 M | $44.73 |
| Q4 2013 | -181,900 | Reduce 9.13% | 1.81 M | $52.81 |
| Q1 2014 | +987,300 | Add 54.56% | 2.8 M | $51.40 |
| Q2 2014 | -563,300 | Reduce 20.14% | 2.23 M | $56.44 |
| Q3 2014 | -1.51 M | Reduce 67.66% | 722,355 | $57.76 |
| Q4 2014 | -504,455 | Reduce 69.83% | 217,900 | $65.44 |
| Q1 2015 | +970,497 | Add 445.39% | 1.19 M | $58.54 |
| Q2 2015 | -1.18 M | Reduce 99.31% | 8,200 | $67.20 |
| Q3 2015 | +2.93 M | Add 35677.51% | 2.93 M | $54.41 |
| Q4 2015 | -2.35 M | Reduce 80.14% | 582,756 | $59.24 |
| Q1 2016 | +980,300 | Add 168.22% | 1.56 M | $57.12 |
| Q2 2016 | -345,456 | Reduce 22.10% | 1.22 M | $61.91 |
| Q3 2016 | +700,856 | Add 57.56% | 1.92 M | $63.07 |
| Q4 2016 | -1.57 M | Reduce 81.71% | 350,800 | $62.62 |
| Q1 2017 | +1.74 M | Add 495.20% | 2.09 M | $65.16 |
| Q2 2017 | +1.13 M | Add 54.23% | 3.22 M | $72.51 |
| Q3 2017 | -1.81 M | Reduce 56.28% | 1.41 M | $88.86 |
| Q4 2017 | -1.41 M | Sold Out | 1.41 M | $0.00 |
| Q1 2018 | +1.76 M | New Buy | 1.76 M | $94.65 |
| Q2 2018 | +606,627 | Add 34.55% | 2.36 M | $92.65 |
| Q3 2018 | -1.14 M | Reduce 48.35% | 1.22 M | $94.58 |
| Q4 2018 | -1.12 M | Reduce 91.84% | 99,500 | $92.19 |
| Q1 2019 | +2.37 M | Add 2386.49% | 2.47 M | $80.59 |
| Q2 2019 | +2.06 M | Add 83.45% | 4.54 M | $72.72 |
| Q3 2019 | +2.77 M | Add 60.99% | 7.31 M | $75.72 |
| Q4 2019 | +4.49 M | Add 61.45% | 11.8 M | $88.54 |
| Q1 2020 | +1.76 M | Add 14.91% | 13.56 M | $76.19 |
| Q2 2020 | +5.47 M | Add 40.32% | 19.02 M | $98.18 |
| Q3 2020 | -5.55 M | Reduce 29.18% | 13.47 M | $87.59 |
| Q4 2020 | -7.41 M | Reduce 54.99% | 6.06 M | $107.15 |
| Q1 2021 | -5.22 M | Reduce 86.03% | 847,037 | $108.22 |
| Q2 2021 | -117,113 | Reduce 13.83% | 729,924 | $112.64 |
| Q3 2021 | +1.34 M | Add 183.71% | 2.07 M | $107.87 |
| Q4 2021 | -17,317 | Reduce 0.84% | 2.05 M | $135.40 |
| Q1 2022 | -1.13 M | Reduce 55.04% | 923,303 | $162.11 |
| Q2 2022 | +427,677 | Add 46.32% | 1.35 M | $153.16 |
| Q3 2022 | -985,578 | Reduce 72.95% | 365,402 | $134.21 |
| Q4 2022 | -26,606 | Reduce 7.28% | 338,796 | $0.16 |
| Q1 2023 | -15,900 | Reduce 4.69% | 322,896 | $0.16 |
| Q2 2023 | +964,212 | Add 298.61% | 1.29 M | $0.13 |
| Q3 2023 | +70,991 | Add 5.52% | 1.36 M | $149.06 |
| Q4 2023 | +638,612 | Add 47.02% | 2 M | $154.97 |
| Q1 2024 | -867,717 | Reduce 43.46% | 1.13 M | $182.10 |
| Q2 2024 | +175,677 | Add 15.56% | 1.3 M | $171.52 |
| Q3 2024 | -167,100 | Reduce 12.81% | 1.14 M | $197.48 |
| Q4 2024 | -164,677 | Reduce 14.48% | 972,894 | $177.70 |
| Q1 2025 | +249,204 | Add 25.61% | 1.22 M | $209.52 |
| Q2 2025 | +739,900 | Add 60.54% | 1.96 M | $185.62 |
| Q3 2025 | -1.03 M | Reduce 52.70% | 928,071 | $231.54 |
Renaissance Technologies's AbbVie Investment FAQs
Renaissance Technologies first purchased AbbVie Inc. (ABBV) in Q2 2013, acquiring 540,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held AbbVie Inc. (ABBV) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to AbbVie Inc. (ABBV) was in Q2 2020, adding 19,021,869 shares worth $1.87 B. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 928,071 shares of AbbVie Inc. (ABBV), valued at approximately $214.89 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.28% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in AbbVie Inc. (ABBV) was 19,021,869 shares, as reported at the end of Q2 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.